The study demonstrated that cancer cells also expressed serpins, including neuroserpin and serpin B2, which inhibits stromal cell-derived plasmin – an L1CAM inactivator, and inducer of cancer cell death via FasL signaling (Figure 3). Here, FASLG is linked to cancer.